Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor?

Hepatobiliary Surg Nutr. 2018 Oct;7(5):403-405. doi: 10.21037/hbsn.2018.07.03.

Author

Oliver A Kent¹

Affiliation

¹ Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, Toronto, Canada.

No abstract available

Publication types

Editorial
Comment